Aagami, Inc.

cross border partnerships strategic consulting india biotech ip acquisition mergers pharma pharma licensing innovation partnerships licensing acquisitions out- licensing market entry india doing lifesciences business in india strategic consulting for india patent cross border partnering global pharma deals global partnering investment technology licensing co-development usa market intelligence drug research in india intellectual property cross border partnership business updates bio europe 2023 merger codevelopment 505(b)(2) nbe nce innovation bd strategy divestiture capital funding biotechnology ip licensing strategic planning consulting business research market research university innovation opportunities for us companies in india india biotech india -us partnership india pharma india aagami india and us dinesh jain godwyn francis india-us aagami india partnering research report india partner technology licen value proposition management consulting performance indicator odds hybrid model top 10 indian pharma companies india patent act 1970 india pharmaceutical industry biosimilar mnc collaboration india ip regime key therapy area r&d pharmaceutical industry who trips drug repurposing re-profiling ndds crams cro drug development india global lifesciences indian subcontinent doing business in india